Loading insider details...
Beta
Latest Form 4 (Mar 23, 2026): Grant/Award of 33,321 EXAS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 23, 2026 | EXACT SCIENCES CORP (EXAS) | Grant/Award | 33,321 | n/a |
| Feb 27, 2026 | EXACT SCIENCES CORP (EXAS) | Grant/Award | 28,063 | n/a |
| Dec 30, 2025 | EXACT SCIENCES CORP (EXAS) | Exercise/Conversion | 3,955 | n/a |
| Nov 6, 2025 | EXACT SCIENCES CORP (EXAS) | Sale | 2,858 | $200.3K |
| Aug 7, 2025 | EXACT SCIENCES CORP (EXAS) | Exercise/Conversion | 5,350 | n/a |
| Mar 4, 2025 | EXACT SCIENCES CORP (EXAS) | Exercise/Conversion | 4,725 | n/a |
| Feb 27, 2025 | EXACT SCIENCES CORP (EXAS) | Exercise/Conversion | 3,954 | n/a |
| Feb 21, 2025 | EXACT SCIENCES CORP (EXAS) | Exercise/Conversion | 1,729 | n/a |
| Oct 9, 2024 | EXACT SCIENCES CORP (EXAS) | Sale | 929 | $65.0K |
| Sep 19, 2024 | EXACT SCIENCES CORP (EXAS) | Sale | 929 | $65.0K |